Endothelial membrane remodeling is obligate for anti-angiogenic radiosensitization during tumor radiosurgery.
While there is significant interest in combining anti-angiogenesis therapy with conventional anti-cancer treatment, clinical trials have as of yet yielded limited therapeutic gain, mainly because mechanisms of anti-angiogenic therapy remain to a large extent unknown. Currently, anti-angiogenic tumor...
Main Authors: | Jean-Philip Truman, Mónica García-Barros, Matthew Kaag, Dolores Hambardzumyan, Branka Stancevic, Michael Chan, Zvi Fuks, Richard Kolesnick, Adriana Haimovitz-Friedman |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-08-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2924400?pdf=render |
Similar Items
-
Endothelial membrane remodeling is obligate for anti-angiogenic radiosensitization during tumor radiosurgery.
by: Jean-Philip Truman, et al.
Published: (2010-09-01) -
Adenoviral transduction of human acid sphingomyelinase into neo-angiogenic endothelium radiosensitizes tumor cure.
by: Branka Stancevic, et al.
Published: (2013-01-01) -
Enhancement of Soft Tissue Sarcoma Response to Gemcitabine through Timed Administration of a Short-Acting Anti-Angiogenic Agent
by: Jin Cheng, et al.
Published: (2020-07-01) -
On the preservation of vessel bifurcations during flow-mediated angiogenic remodelling.
by: Lowell T Edgar, et al.
Published: (2021-02-01) -
The Angiogenic Effects of β-endorphin in Endothelial Cells
by: Yu-Shan Chen, et al.
Published: (2011)